|
|
|
| Effect of Self-made Yiai decoction Combined with XELOX on Postoperative Outcomes of Gastric Cancer |
| YIN Ting-li |
| Oncology Department, Santai Hospitals Affiliated to North Sichuan Medical College,Sichuan Province 621100 |
|
|
|
|
Abstract 【Objective】 To investigate the effects of self-made Yiai decoction combined with capecitabine and oxaliplatin (XELOX regimen) on tumor markers, susceptibility genes and quality of life of patients with gastric cancer after operation. 【Methods】 A total of 86 cases of patients with gastric cancer treated who underwent radical gastrectomy were randomly divided into two groups, with 43 cases in each group. Patients in the control group received XELOX chemotherapy after operation, while patients in the combined group received self-made Yiai decoction combined with XELOX regimen. The curative effects were compared between the two groups. 【Results】 After chemotherapy the levels of carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199, gastrin and vasoactive intestinal peptide in the two groups were significantly decreased (P<0.05), while mRNA levels of breast cancer susceptibility gene 1 and breast cancer susceptibility gene 2 were significantly increased (P<0.05). The physical, functional, social family, emotional, doctor-patient relationship and cancer additional attention scores were significantly improved (P<0.05). Those changes in the combined group were more remarkable than in the control group (P<0.05). The degree of bone marrow suppression in the combined group was significantly lower than that in the control group (P<0.05). 【Conclusion】 Self-made Yiai decoction can significantly improve the curative effect of XELOX chemotherapy after radical gastrectomy, reduce the levels of serum tumor markers, and improve the quality of life of patients.
|
|
Received: 08 May 2017
|
|
|
|
|
|
[1] 鲁加煜,张勇.复方蟾酥注射液用于胃癌患者术后化疗的临床研究[J].医学临床研究,2017,34(2):243-282.
[2] 房玮,吴红卫,李莹莹.中药联合化疗治疗胃癌的临床效果分析[J].实用癌症杂志,2015,30(11):1668-1671.
[3] 胡祥.2014年第4版日本《胃癌治疗指南》更新要旨[J].中国实用外科杂志,2015,35(1):16-19.
[4] 李星,樊巧玲.胃癌中医辨证与方药应用的文献研究[J].中医杂志,2017,58(8):693-696.
[5] 张建国,郑国宝.热疗联合化疗对中晚期胃癌的疗效观察[J].中国基层医药,2017,24(4):570-574.
[6] 王亚坤,谢长生,楼金杰,等.中医药治疗胃癌的实验研究进展[J].中华中医药学刊,2015,33(11):2743-2745.
[7] 何广思.替吉奥单药与XELOX方案一线治疗老年晚期胃癌的疗效比较[J].蚌埠医学院学报,2017,42(2):185-188.
[8] 杨兰,邓颖,胡洪林,等.奥沙利铂分别联合卡培他滨及5-氟尿嘧啶/亚叶酸钙治疗晚期胃癌的疗效观察[J].实用医院临床杂志,2015,12(2):79-81.
[9] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
[10] 胡洪亮.益气健脾抗癌汤联合化疗治疗胃癌41例[J].环球中医药,2016,9(8):996-998.
[11] Shim HJ. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin[J].Cancer Sci,2010,101(5):1247-1254. |
|
|
|
2020, Vol. 37 
